<DOC>
	<DOCNO>NCT02815111</DOCNO>
	<brief_summary>The purpose research study see pain well control few side effect . The new drug regimen study several different medicine different way treat pain .</brief_summary>
	<brief_title>Evaluation Ketamine Multi-modal Analgesics</brief_title>
	<detailed_description>The investigator plan study analgesic regimen Ketamine Lidocaine infusion Neurontin acetaminophen deliver orally postoperative analgesia subsequent effect ventilator day ICU stay . The investigator expect pain score either unchanged good historic control . In addition , investigator expect ventilator day ICU stay improve due reduce incidence delirium bowel dysfunction .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>American Society Anesthesiologists ( ASA ) status 14 Undergoing plan surgery cardiac problem 18 year age old 85 year age Severe liver disease ( alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , bilirubin &gt; 2.5 time Upper Limit Normal ) Pregnancy currently breastfeed History schizophrenia hallucinatory psychiatric disorder History chronic preexisting pain disorder History heart block Severe renal impairment Creatinine Clearance ( CrCl ) &lt; 30 milliliter ( mL ) /min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>